期刊文献+

可见光和近红外荧光分光融合成像外科手术导航系统的研制 被引量:9

Development of a Surgical Navigation System with Beam Split and Fusion of the Visible and Near-Infrared Fluorescence
原文传递
导出
摘要 本文提出研制一种在开放手术过程中无创、实时、定位的外科手术光学导航系统。系统设计依据近红外荧光分子成像原理,采用活体荧光激发技术以及多通道分光摄像技术和图像融合软件技术。研制过程中将可见光和近红外光环形LED激发光源、多通道带通滤光片、分光摄像2CCD光电传感器和计算机系统技术集成,成功研制出一种新型外科手术光学导航系统。该系统在活体注射近红外荧光显影剂时,能够显示同一部位、同一时刻手术野组织表面的解剖学图像和近红外荧光功能图像。解决了医生在术中肉眼难以识别淋巴管、淋巴结、肿瘤边缘的技术问题,实现实时、无创的外科手术导航,有效引导外科医生切除肿瘤组织,显著提高手术成功率。该项技术已获得国家专利,专利号为ZI.2011 1 0292374.1。 This paper presents a surgical optical navigation system with non-invasive,real-time,and positioning characteristics for open surgical procedure.The design was based on the principle of near-infrared fluorescence molecular imaging.The in vivo fluorescence excitation technology,multi-channel spectral camera technology and image fusion software technology were used.Visible and near-infrared light ring LED excitation source,multi-channel band pass filters,spectral camera 2CCD optical sensor technology and computer systems were integrated,and,as a result,a new surgical optical navigation system was successfully developed.When the near-infrared fluorescence was injected,the system could display anatomical images of the tissue surface and near-infrared fluorescent functional images of surgical field simultaneously.The system can identify the lymphatic vessels,lymph node,tumor edge which doctor cannot find out with naked eye intra-operatively.Our research will guide effectively the surgeon to remove the tumor tissue to improve significantly the success rate of surgery.The technologies have obtained a national patent,with patent No.ZI.2011 1 0292374.1.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2015年第2期455-459,共5页 Journal of Biomedical Engineering
基金 国家科技部中小企业技术创新基金资助项目(12C26211400913)
关键词 可见光 近红外荧光 分光融合 外科手术 导航 visible light near-infrared fluorescence beam split and fusion surgical operation navigation
  • 相关文献

参考文献21

  • 1BJORNSSON O G, MURPHY R, CHADWICK V S. Physio- chemical studies of indocyanine green (ICG) : absorbance/concen- tration relationship, pH tolerance and assay precision in various solvents [J]. Experientia, 1982, 38(12) : 1441-1442.
  • 2FRANGIONI J V. In vivo near-infrared fluorescence imaging [J]. Current Opinion in Chemical Biology, 2003, 7(5) : 626-634.
  • 3ALFORD R, SIMPSON H M, DUBERMAN J, et al. Toxic- ity of organic fluorophores used in molecular imaging: litera- ture review[J]. Molecular Imaging, 2009, 8(6): 341-354.
  • 4SCHAAFSMA B E, MIEOG J S, HUTTEMAN M, et al. The clinical use of indocyaninegreen as near-infrared fluores- cent contrast agent for image-guided oncologicsurgery [J]. J SurgOncol. 2011; 104(3): 323-332.
  • 5POLOM K, MURAWA D, RHO Y S, et al. Current trends and emerging future of indocyanine green usage in surgery and oncology., a literature review[J]. Cancer, 2011, 117 (21) : 4812-4822.
  • 6LUO S, ZHANG E, SU Y, et al. A review of NIR dyes in cancer targeting and imaging [J]. Biomaterials, 2011, 32(29) : 7127-7138.
  • 7MARSHALL M V, RASMUSSEN J C, TAN I C, et al. Near-infrared fluorescence imaging in humans with indoeya- nine green: a review and update [J]. Open Surg Oncol J (On- line), 2010, 2(2): 12-25.
  • 8VAHRMEIJER A L, HUTTEMAN M, VAN DER VORST J R, et al. Image guided cancer surgery using near-infrared fluorescence [J]. Nat Rev Clin Oncol. 2013,10(9) : 507-518.
  • 9SEVICK-MURACA E M. Translation of near-infrared fluo- rescence imaging technologies: emerging clinical applications [J]. Annual Review of Medicine, 2012, 63: 217-231.
  • 10ALANDER J T, KAARTINEN I, LAAKSO A, et al. A review of indocyanine green fluorescent imaging in surgery [J]. Interna- tional Journal of Biomedical Imaging, 2012, 2012:940585.

同被引文献64

  • 1Center MM, Jenml A, Lortet-Tieulent J, et al. International vari- ation in prostate cancer incidence and mortality rates. Eur Urol, 2012, 61(6) : 1079-1092.
  • 2Weingartner K, Ramaswamy A, Bittinger A, et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: Results of an autopsy study and implications for the clinic. J Urol, 1996, 156(6) : 1969-1971.
  • 3Heidenreich A, Varga Z, Van Knobloch R. Extended pelvic lymph-adenectomy in patients undergoing radical prostatectomy : High in- cidence of lymph node metastasis. J Urol, 2002, 167 (4) : 1681- 1686.
  • 4Rousseau C, Rousseau T, Campion L, et al. Laparoscopic senti- nel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinonm: A prospective study of 200 patients. J Nucl Med, 2014, 55(5) : 753-758.
  • 5Cabanas RM. An approach for the treatment of penile carcinoma. Cancer, 1977, 39(2) : 456-466.
  • 6Wawroschek F, Vogt H, Weckermann D, et al. The sentinel lymph node concept in prostate cancer -- first results of gamma probe-guided sentinel lymph node identification. Eur Urol, 1999, 36(6) : 595-600.
  • 7van der Poel HG, Buckle T, Brouwer OR, et al. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients : Clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol, 2011, 60(4) : 826-833.
  • 8Manny TB, Patel M, Hemal AK. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: The initial clinical experience in 50 patients. Eur Urol, 2014, 65(6) : 1162-1168.
  • 9Van Den Berg NS, Buckle T, Kleinjan GI, et al. Hybrid tracers for sentinel node biopsy. Q J Nucl Med Mol hnaging, 2014, 58 (2) : 193-206.
  • 10Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritunmral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgm'y, 2002, 131(3) : 277-286.

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部